Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for DBV Technologies S.A. (DBVT)

« Back to company index

DBVT Chatter Timeline

Stock Ticker for DBVT

Most Active Tweeters for DBVT

UserTweets
@Sports_bios 3
@Gambiste1 2
@AlertTrade 2
@JonathanWexler3 1
@biofeed 1

Recent Tweets for DBVT

TheMarketsDaily @TheMarketsDaily
DBV TECHNOLOGIE/S $DBVT Sees Unusually-High Trading Volume https://t.co/shilwjXM7n
September 13th 2019, 11:09pm
bal221 @bal221
@JonathanWexler3 $DBVT - Having a less potent and safer desensitizing patch on the market that may not require such… https://t.co/mAEqLZcJgL
September 13th 2019, 10:09pm
JonathanWexler3 @JonathanWexler3
$DBVT - the entire argument for their singular trial being sufficient for approval was that they’re safe. They miss… https://t.co/pq4huRazg6
September 13th 2019, 7:09pm
Gambiste1 @Gambiste1
RT @YaChristle: @fierro7676 hi I like $aimt and $dbvt
September 13th 2019, 6:09pm
YaChristle @YaChristle
@fierro7676 hi I like $aimt and $dbvt
September 13th 2019, 6:09pm
BertrandBio @BertrandBio
What I was writing about $DBVT vs $AIMT 3.5y ago after the AAAAI meeting... Things can revert rapidly. 1.5y later… https://t.co/D2B8N6IR5T
September 13th 2019, 5:09pm
AlertTrade @AlertTrade
SOCIAL ACTIVITY: $DBVT - DBV Technologies SA American ? TradeIdeas via ? https://t.co/VS8RO1bzXJ
September 13th 2019, 4:09pm
BTLipschultz @BTLipschultz
Using shares of $DBVT as a proxy of how the $aimt panel is going? ADRs rose as much as 7.8% (still within its recen… https://t.co/LTrGDcv1iI
September 13th 2019, 1:09pm
hiddensmallcaps @hiddensmallcaps
$AIMT halted pending decision review by FDA. No position but this and $DBVT are playing in a potentially enormous m… https://t.co/XavK7MqHRE
September 13th 2019, 11:09am
Sports_bios @Sports_bios
@WilliamGerber1 You are right on the mark - $DBVT doesn;t have the data on such population.. knowing the landscape… https://t.co/WLyutcIOL8
September 12th 2019, 6:09am
Gambiste1 @Gambiste1
RT @biofeed: $DBVT tmrw
September 12th 2019, 12:09am
biofeed @biofeed
$DBVT tmrw
September 11th 2019, 10:09pm
WilliamGerber1 @WilliamGerber1
@Sports_bios Unfortunately $DBVT went a different direction - their P3 trial treated patients with higher threshold… https://t.co/cNzbL1svJ9
September 11th 2019, 8:09pm
Sports_bios @Sports_bios
With $DBVT patches, they need to have patients to get some sort of sensitivity test regularly.. Me in the camp of t… https://t.co/8So3osYcxI
September 11th 2019, 6:09pm
Sports_bios @Sports_bios
After $AIMT - $DBVT is next - will FDA accept the BLA?? That;s the big Q.. Assume it does, the role the patches p… https://t.co/m3zf3i3a6Z
September 11th 2019, 6:09pm
AlertTrade @AlertTrade
RT @theflynews: Aimmune jumps as FDA materials seen as good sign for peanut allergy treatment $AIMT $DBVT https://t.co/YP1qlXxxcs https://t…
September 11th 2019, 12:09pm
theflynews @theflynews
Aimmune jumps as FDA materials seen as good sign for peanut allergy treatment $AIMT $DBVT https://t.co/YP1qlXxxcs https://t.co/IMFps9HYxw
September 11th 2019, 12:09pm
TickerReport @TickerReport
Brokerages Expect DBV TECHNOLOGIE/S $DBVT to Announce -$0.52 Earnings Per Share https://t.co/5y0yo7cZ6T
September 9th 2019, 1:09pm
TickerReport @TickerReport
DBV TECHNOLOGIE/S $DBVT Cut to “Sell” at BidaskClub https://t.co/1HnAF8vnr6
August 11th 2019, 5:08am
registrarjourn @registrarjourn
DBV TECHNOLOGIE/S $DBVT Cut to “Hold” at Zacks Investment Research https://t.co/yVOrrNOHOs
August 10th 2019, 6:08pm
EnterpriseLeade @EnterpriseLeade
DBV TECHNOLOGIE/S $DBVT Cut to “Hold” at Zacks Investment Research https://t.co/LIupeub3aa
August 10th 2019, 6:08pm
dispatchtribune @dispatchtribune
DBV TECHNOLOGIE/S $DBVT Cut to “Hold” at Zacks Investment Research https://t.co/mw3oapT4YE
August 10th 2019, 6:08pm
ZolmaxNews @ZolmaxNews
DBV TECHNOLOGIE/S $DBVT Downgraded by BidaskClub https://t.co/wqnB4vJnTC
August 10th 2019, 2:08pm
ThisLincolnian @ThisLincolnian
DBV TECHNOLOGIE/S $DBVT Downgraded by BidaskClub https://t.co/RwZCMZuW0N
August 10th 2019, 2:08pm
WatchlistN @WatchlistN
DBV TECHNOLOGIE/S $DBVT Sees Unusually-High Trading Volume https://t.co/LBh9qfSREI
August 10th 2019, 2:08pm
dakotafinancial @dakotafinancial
DBV TECHNOLOGIE/S $DBVT Downgraded by Zacks Investment Research https://t.co/XMihJVAPZs
August 9th 2019, 5:08pm
MLTherapeutics @MLTherapeutics
@DBVTechnologies $DBVT Submits BLA to U.S. FDA for Viaskin Peanut for the Treatment of #peanutallergy https://t.co/GZNA0pUvFf
August 9th 2019, 12:08am
stocknewstimes @stocknewstimes
DBV TECHNOLOGIE/S $DBVT Sees Unusually-High Trading Volume https://t.co/tQl60D2DMs
August 8th 2019, 11:08pm
macondailynews @macondailynews
DBV TECHNOLOGIE/S $DBVT Sees Unusually-High Trading Volume https://t.co/JB68TE7vqm
August 8th 2019, 11:08pm
AjTrader7 @AjTrader7
RT @4topstocks: Traded $DBVT today which was gapping up 1.50 on FDA application news. So what? In my mind I heard AJ scream SHORT. Lol. Gl…
August 8th 2019, 5:08pm
4topstocks @4topstocks
Traded $DBVT today which was gapping up 1.50 on FDA application news. So what? In my mind I heard AJ scream SHORT.… https://t.co/LJqFhyN7Ek
August 8th 2019, 5:08pm
dakotafinancial @dakotafinancial
DBV TECHNOLOGIE/S $DBVT Downgraded by BidaskClub to “Sell” https://t.co/MHNcdOTo4N
August 8th 2019, 1:08pm
ProVesting @ProVesting
$DBVT: DBV Resubmits Regulatory Application For Peanut Allergy Drug …: https://t.co/oBujXp9Bzg
August 8th 2019, 10:08am
ProVesting @ProVesting
$DBVT $HEXO: 25 Healthcare Stocks Moving In Today’s Pre-Market Session: https://t.co/ADE3n59qpu
August 8th 2019, 8:08am
MarketCurrents @MarketCurrents
$DBVT - DBV Tech up 17% premarket on Viaskin Peanut application in U.S. https://t.co/IvfV134oF8
August 8th 2019, 8:08am
MarketChmln @MarketChmln
$DBVT gains in premarket trading. See the latest news. https://t.co/FJC8Uy2eGe https://t.co/sucudQgYNr
August 8th 2019, 8:08am
BankTheTrade @BankTheTrade
$DBVT(9.14) up 1.50 on FDA peanut allergy application
August 8th 2019, 6:08am
zoom530 @zoom530
$DBVT SHORT $10.61 with 2K shares. Just read the news. Good night everyone. ???????????? https://t.co/2r1oVglq9d
August 8th 2019, 5:08am
portefeuillefun @portefeuillefun
RT @biotechradar_eu: DBV Technologies $DBV $DBVT Submits Biologics License Application to U.S. Food and Drug Administration for Viaskin Pea…
August 7th 2019, 5:08pm
biotechradar_eu @biotechradar_eu
DBV Technologies $DBV $DBVT Submits Biologics License Application to U.S. Food and Drug Administration for Viaskin… https://t.co/o0V3xLhPUE
August 7th 2019, 4:08pm
Stock_News_Now @Stock_News_Now
$DBVT: New SEC Filing for DBVT: Form 6-K (No. 0001193125-19-215368): https://t.co/pb9EmYzpq2
August 7th 2019, 4:08pm
TranscriptDaily @TranscriptDaily
DBV TECHNOLOGIE/S $DBVT Forecasted to Earn FY2023 Earnings of $1.55 Per Share https://t.co/JsEp7rIJM2
August 7th 2019, 6:08am
Gambiste1 @Gambiste1
RT @TradeFlags: TD BUY $DBVT at 8.95, Supp 8.70 Resis 10.10 R16 HiLo 24% T1Y 20 buy 2.3 fwdPE -2.0 DIV N/A #DBV Techno #stocks #trading #f…
August 7th 2019, 4:08am
TradeFlags @TradeFlags
TD BUY $DBVT at 8.95, Supp 8.70 Resis 10.10 R16 HiLo 24% T1Y 20 buy 2.3 fwdPE -2.0 DIV N/A #DBV Techno #stocks… https://t.co/ei6li5B5X0
August 7th 2019, 12:08am
dailypoliticaln @dailypoliticaln
DBV TECHNOLOGIE/S $DBVT Stock Rating Lowered by Zacks Investment Research https://t.co/zl1lqjIvYE
August 6th 2019, 10:08pm
macondailynews @macondailynews
DBV TECHNOLOGIE/S $DBVT Receives $12.91 Average Price Target from Analysts https://t.co/uIj3yaxNyU
August 5th 2019, 1:08pm
TheMarketsDaily @TheMarketsDaily
DBV TECHNOLOGIE/S $DBVT Receives $12.91 Consensus Target Price from Analysts https://t.co/I6zBZiAhtc
August 5th 2019, 1:08pm
TranscriptDaily @TranscriptDaily
ValuEngine Upgrades DBV TECHNOLOGIE/S $DBVT to Buy https://t.co/h5FPAm5HAT
August 5th 2019, 11:08am
WeekHerald @WeekHerald
ValuEngine Upgrades DBV TECHNOLOGIE/S $DBVT to Buy https://t.co/wxZDX52YIc
August 5th 2019, 11:08am
AmericanBanking @AmericanBanking
Jefferies Financial Group Weighs in on DBV TECHNOLOGIE/S’s FY2023 Earnings $DBVT https://t.co/Itddg9jH0s #stocks
August 5th 2019, 5:08am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.